We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$7.49B
AUM Growth
+$961M
Cap. Flow
+$242M
Cap. Flow %
3.23%
Top 10 Hldgs %
55.66%
Holding
3,668
New
212
Increased
1,637
Reduced
1,002
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 11.25%
2 Financials 4.58%
3 Consumer Discretionary 3.5%
4 Industrials 2.82%
5 Healthcare 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PZZA icon
2476
Papa John's
PZZA
$999M
$14.8K ﹤0.01%
403
-9
-2% -$311
HYD icon
2477
VanEck High Yield Muni ETF
HYD
$4.44B
$14.8K ﹤0.01%
288
-82
-22% -$4.19K
UNF icon
2478
Unifirst Corp
UNF
$5.32B
$14.8K ﹤0.01%
56
+42
+300% +$11K
AGIO icon
2479
Agios Pharmaceuticals
AGIO
$2.16B
$14.8K ﹤0.01%
399
BOOT icon
2480
Boot Barn
BOOT
$4.55B
$14.8K ﹤0.01%
90
+56
+165% +$9.08K
CLB icon
2481
Core Laboratories
CLB
$538M
$14.8K ﹤0.01%
1,267
-177
-12% -$2.53K
EWTX icon
2482
Edgewise Therapeutics
EWTX
$4.39B
$14.7K ﹤0.01%
363
ARCT icon
2483
Arcturus Therapeutics
ARCT
$157M
$14.7K ﹤0.01%
2,188
SPSM icon
2484
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$14.7K ﹤0.01%
255
-3
-1% -$160
HCSG icon
2485
Healthcare Services Group
HCSG
$1.56B
$14.7K ﹤0.01%
598
+496
+486% +$10.5K
ALLO icon
2486
Allogene Therapeutics
ALLO
$601M
$14.7K ﹤0.01%
7,057
-1,793
-20% -$3.94K
CRAI icon
2487
CRA International
CRAI
$1.1B
$14.7K ﹤0.01%
103
+19
+23% +$2.86K
CERT icon
2488
Certara
CERT
$1.17B
$14.6K ﹤0.01%
2,235
+2,028
+980% +$11.4K
JQC icon
2489
Nuveen Credit Strategies Income Fund
JQC
$702M
$14.6K ﹤0.01%
+3,000
New +$14.5K
XTL icon
2490
State Street SPDR S&P Telecom ETF
XTL
$581M
$14.6K ﹤0.01%
64
IBEX icon
2491
IBEX
IBEX
$448M
$14.5K ﹤0.01%
479
+421
+726% +$12.5K
CPRI icon
2492
Capri Holdings
CPRI
$1.77B
$14.5K ﹤0.01%
782
+22
+3% +$422
CWH icon
2493
Camping World
CWH
$363M
$14.5K ﹤0.01%
1,899
+1,556
+454% +$11.3K
CRNX icon
2494
Crinetics Pharmaceuticals
CRNX
$8.86B
$14.5K ﹤0.01%
387
-123
-24% -$4.57K
VCLT icon
2495
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.83B
$14.4K ﹤0.01%
192
-7
-4% -$525
CTBI icon
2496
Community Trust Bancorp
CTBI
$1.38B
$14.4K ﹤0.01%
199
+48
+32% +$3.2K
KEEL
2497
Keel Infrastructure Corp
KEEL
$2.57B
$14.3K ﹤0.01%
+2,500
New +$10.7K
DNOW icon
2498
DNOW Inc
DNOW
$2.63B
$14.2K ﹤0.01%
1,098
LYFT icon
2499
Lyft
LYFT
$5.39B
$14.2K ﹤0.01%
973
-124
-11% -$1.73K
TRVI icon
2500
Trevi Therapeutics
TRVI
$2.49B
$14.1K ﹤0.01%
758

Similar funds

SignatureFD's Q2 2026 Portfolio in Review

As of Q2 2026, SignatureFD held 3,668 positions worth $7.49B, up 15% from $6.53B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

SignatureFD deployed $242M of net new capital in Q2 2026, opening 212 new positions and adding to 1,637 existing holdings. Its largest new stake was Innovator Equity Dual Directional 15 Buffer ETF - April: 399,063 shares worth $8.06M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Large-Cap ETF, an estimated $9.11M trimmed.

  • SignatureFD's largest Q2 2026 buy was Innovator Equity Dual Directional 15 Buffer ETF - April: 399,063 shares worth $8.06M.
  • SignatureFD added most to iShares Core S&P US Value ETF in Q2 2026, an estimated $24.8M increase.
  • SignatureFD's biggest Q2 2026 reduction was Vanguard Large-Cap ETF, cutting an estimated $9.11M.
  • SignatureFD fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q2 2026, selling an estimated $519K.
  • SignatureFD's ten largest holdings make up 56% of its $7.49B portfolio in Q2 2026.
  • SignatureFD opened 212 new positions and closed 157 in Q2 2026.
  • SignatureFD's portfolio value rose 15% quarter-over-quarter to $7.49B.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.